Mayer Bryan T, Krantz Elizabeth M, Swan David, Ferrenberg James, Simmons Karen, Selke Stacy, Huang Meei-Li, Casper Corey, Corey Lawrence, Wald Anna, Schiffer Joshua T, Gantt Soren
Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
University of British Columbia, BC Children's Hospital Research Institute, Vancouver, Canada.
J Virol. 2017 May 26;91(12). doi: 10.1128/JVI.00380-17. Print 2017 Jun 15.
Cytomegalovirus (CMV) is acquired by the oral route in children, and primary infection is associated with abundant mucosal replication, as well as the establishment of latency in myeloid cells that results in lifelong infection. The efficiency of primary CMV infection in humans following oral exposure, however, is unknown. We consistently detected self-limited, low-level oral CMV shedding events, which we termed transient CMV infections, in a prospective birth cohort of 30 highly exposed CMV-uninfected infants. We estimated the likelihood of transient oral CMV infections by comparing their observed frequency to that of established primary infections, characterized by persistent high-level shedding, viremia, and seroconversion. We developed mathematical models of viral dynamics upon initial oral CMV infection and validated them using clinical shedding data. Transient infections comprised 76 to 88% of oral CMV shedding events. For this high percentage of transient infections to occur, we identified two mathematical prerequisites: a very small number of initially infected oral cells (1 to 4) and low viral infectivity (<1.5 new cells infected/cell). These observations indicate that oral CMV infection in infants typically begins with a single virus that spreads inefficiently to neighboring cells. Thus, although the incidence of CMV infection is high during infancy, our data provide a mechanistic framework to explain why multiple CMV exposures are typically required before infection is successfully established. These findings imply that a sufficiently primed immune response could prevent CMV from establishing latent infection in humans and support the achievability of a prophylactic CMV vaccine. CMV infects the majority of the world's population and is a major cause of birth defects. Developing a vaccine to prevent CMV infection would be extremely valuable but would be facilitated by a better understanding of how natural human CMV infection is acquired. We studied CMV acquisition in infants and found that infections are usually brief and self-limited and are successfully established relatively rarely. Thus, although most people eventually acquire CMV infection, it usually requires numerous exposures. Our analyses indicate that this is because the virus is surprisingly inefficient, barely replicating well enough to spread to neighboring cells in the mouth. Greater knowledge of why CMV infection usually fails may provide insight into how to prevent it from succeeding.
巨细胞病毒(CMV)在儿童中通过口腔途径获得,原发性感染与丰富的黏膜复制以及在髓样细胞中建立潜伏感染相关,这种潜伏感染会导致终身感染。然而,人类经口接触后原发性CMV感染的效率尚不清楚。在一个由30名CMV高度暴露但未感染的婴儿组成的前瞻性出生队列中,我们持续检测到自限性、低水平的口腔CMV脱落事件,我们将其称为短暂性CMV感染。通过将观察到的短暂性口腔CMV感染频率与以持续高水平脱落、病毒血症和血清学转换为特征的已确诊原发性感染频率进行比较,我们估计了短暂性口腔CMV感染的可能性。我们建立了初次口腔CMV感染时病毒动力学的数学模型,并使用临床脱落数据对其进行了验证。短暂性感染占口腔CMV脱落事件的76%至88%。为了出现如此高比例的短暂性感染,我们确定了两个数学前提条件:最初感染的口腔细胞数量非常少(1至4个)以及病毒感染性低(每个细胞感染新细胞数<1.5个)。这些观察结果表明,婴儿的口腔CMV感染通常始于单个病毒,该病毒向邻近细胞的传播效率低下。因此,尽管婴儿期CMV感染的发生率很高,但我们的数据提供了一个机制框架,以解释为什么通常需要多次接触CMV才能成功建立感染。这些发现意味着充分启动的免疫反应可以预防CMV在人类中建立潜伏感染,并支持预防性CMV疫苗的可行性。CMV感染了世界上大多数人口,是出生缺陷的主要原因。开发一种预防CMV感染的疫苗将极其有价值,但更好地了解人类自然感染CMV的方式将有助于实现这一目标。我们研究了婴儿感染CMV的情况,发现感染通常是短暂的且自限性的,相对很少能成功建立感染。因此,尽管大多数人最终会感染CMV,但通常需要多次接触。我们的分析表明,这是因为该病毒的效率出奇地低,几乎无法很好地复制以传播到口腔中的邻近细胞。对CMV感染通常失败原因的更多了解可能会为如何防止其成功提供见解。